Abiopharma

🔍 WEIGAND DAVID E (Executive)

Company: Super Micro Computer, Inc. (SMCI)

Report Date: 2026-08-10

Detailed Transactions and Holdings:

• Acquired 1,480 shares of Common Stock (Direct)
  Date: 2026-08-10 | Code: M | equity_swap_involved: 0 | shares_owned_after: 132,292.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 754 shares of Common Stock at $31.46 per share (Direct)
  Date: 2026-08-10 | Code: F | equity_swap_involved: 0 | shares_owned_after: 131,538.00 | transaction_form_type: 4 | Footnotes: F2
• Sold 1,480 shares of Restricted Stock Units (Derivative)
  Date: 2026-08-10 | Code: M | equity_swap_involved: 0 | shares_owned_after: 10,410.00 | transaction_form_type: 4 | Footnotes: F1, F3, F3

Footnotes:

• F1: Each restricted stock unit represents a contingent right to receive one share of SMCI common stock.
• F2: Represents shares of SMCI common stock that have been withheld by SMCI to satisfy tax withholding and remittance obligations in connection with the net settlement of vested restricted stock units and not a market transaction. Transaction exempt from Section 16(b) of the Securities Exchange Act of 1934 (the "Act") pursuant to Rule 16b-3(e) promulgated under the Act.
• F3: Subject to the Reporting Person's continued service to SMCI, the restricted stock units vest at the rate of 25% of the total number of units on May 10, 2025 and 1/16th at the end of each three-month period thereafter. Vested units are settled in shares of SMCI common stock.